Regenxbio Accounts Payable from 2010 to 2025

RGNX Stock  USD 8.21  0.49  5.63%   
Regenxbio Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable is likely to outpace its year average in 2025. Accounts Payable is the amount Regenxbio owes to suppliers or vendors for products or services received but not yet paid for. It represents Regenxbio's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2013-12-31
Previous Quarter
19.5 M
Current Value
22.8 M
Quarterly Volatility
8.8 M
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17 M, Interest Expense of 16.3 M or Selling General Administrative of 50.8 M, as well as many indicators such as Price To Sales Ratio of 4.36, Dividend Yield of 0.0 or PTB Ratio of 1.55. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Regenxbio over the last few years. An accounting item on the balance sheet that represents Regenxbio obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Regenxbio are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Regenxbio's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Regenxbio Accounts Payable Regression Statistics

Arithmetic Mean8,655,744
Geometric Mean2,892,349
Coefficient Of Variation114.91
Mean Deviation8,351,180
Median4,832,000
Standard Deviation9,946,636
Sample Variance98.9T
Range26.9M
R-Value0.90
Mean Square Error20.5T
R-Squared0.81
Slope1,876,686
Total Sum of Squares1484T

Regenxbio Accounts Payable History

202523.9 M
202422.8 M
202322.8 M
202227.2 M
202111.4 M
202010.6 M
20196.4 M

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable22.8 M23.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.